Condition
Usher Syndromes
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04355689Phase 1Active Not RecruitingPrimary
Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
NCT05355415Recruiting
Adaptive Optics Imaging of Outer Retinal Diseases
NCT03901391Completed
Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa
NCT04665726RecruitingPrimary
Natural History Study of Usher Syndrome ( Light4Deaf )
NCT03990727Unknown
Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.
Showing all 5 trials